Literature DB >> 23157146

Diagnosis and management of gonococcal infections.

Mejebi T Mayor1, Michelle A Roett, Kelechi A Uduhiri.   

Abstract

Neisseria gonorrhoeae causes urogenital, anorectal, conjunctival, and pharyngeal infections. Urogenital tract infections are most common. Men with gonorrhea may present with penile discharge and dysuria, whereas women may present with mucopurulent discharge or pelvic pain; however, women often are asymptomatic. Neonatal infections include conjunctivitis and scalp abscesses. If left untreated, gonorrhea may cause pelvic inflammatory disease in women, or it may disseminate, causing synovial and skin manifestations. Urogenital N. gonorrhoeae infection can be diagnosed using culture or nucleic acid amplification testing. Urine nucleic acid amplification tests have a sensitivity and specificity comparable to those of cervical and urethral samples. Fluoroquinolones are no longer recommended for the treatment of gonorrhea because of antimicrobial resistance. A single intramuscular injection of ceftriaxone, 250 mg, is first-line treatment for uncomplicated urogenital, anorectal, or pharyngeal gonococcal infections. This dosage is more effective for common pharyngeal infections than the previously recommended dose of 125 mg. Ceftriaxone should routinely be accompanied by azithromycin or doxycycline to address the likelihood of coinfection with Chlamydia trachomatis. Azithromycin may be used as an alternative treatment option for patients with previous allergic reactions to penicillin, but because of the likelihood of antimicrobial resistance, its use should be limited. Gonococcal infection should prompt physicians to test for other sexually transmitted infections, including human immunodeficiency virus. Because of high reinfection rates, patients should be retested in three to six months. The U.S. Preventive Services Task Force recommends screening for gonorrhea in all sexually active women at increased risk of infection. It also recommends intensive behavioral counseling for persons with or at increased risk of contracting sexually transmitted infections. Condom use is an effective strategy to reduce the risk of infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23157146

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  17 in total

1.  Microbiological Characteristics of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in South African Women.

Authors:  Jan Henk Dubbink; Dewi J de Waaij; Myrte Bos; Lisette van der Eem; Cécile Bébéar; Nontembeko Mbambazela; Sander Ouburg; Remco P H Peters; Servaas A Morré
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

2.  Neisseria gonorrhoeae Crippled Its Peptidoglycan Fragment Permease To Facilitate Toxic Peptidoglycan Monomer Release.

Authors:  Jia Mun Chan; Joseph P Dillard
Journal:  J Bacteriol       Date:  2016-10-07       Impact factor: 3.490

3.  Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining.

Authors:  Liang-Chun Wang; Jacob Wagner; Annabelle Capino; Elizabeth Nesbit; Wenxia Song; Daniel C Stein
Journal:  J Vis Exp       Date:  2019-02-08       Impact factor: 1.355

4.  Evaluation of the Hologic Aptima Combo 2 Assay for Detection of Neisseria gonorrhoeae from Joint Fluid Specimens.

Authors:  David C Alexander; Robert M Taylor; Irene Martin; Heather Adam; Philippe Lagacé-Wiens; Peter Pieroni; James A Karlowsky; Paul Van Caeseele
Journal:  J Clin Microbiol       Date:  2022-03-23       Impact factor: 11.677

5.  Aminomethyl Spectinomycins as Therapeutics for Drug-Resistant Gonorrhea and Chlamydia Coinfections.

Authors:  Michelle M Butler; Samanthi L Waidyarachchi; Kristie L Connolly; Ann E Jerse; Weirui Chai; Richard E Lee; Stephan A Kohlhoff; Dean L Shinabarger; Terry L Bowlin
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

Review 6.  Pathogenesis of Neisseria gonorrhoeae in the female reproductive tract: neutrophilic host response, sustained infection, and clinical sequelae.

Authors:  Jacqueline S Stevens; Alison K Criss
Journal:  Curr Opin Hematol       Date:  2018-01       Impact factor: 3.284

7.  Primary health clinic toilet/bathroom surface swab sampling can indicate community profile of sexually transmitted infections.

Authors:  Philip M Giffard; Jiunn-Yih Su; Patiyan Andersson; Deborah C Holt
Journal:  PeerJ       Date:  2017-06-22       Impact factor: 2.984

8.  Neisseria gonorrhoeae Aggregation Reduces Its Ceftriaxone Susceptibility.

Authors:  Liang-Chun Wang; Madeline Litwin; Zahraossadat Sahiholnasab; Wenxia Song; Daniel C Stein
Journal:  Antibiotics (Basel)       Date:  2018-06-15

9.  Sexually transmitted infections among patients with herpes simplex virus at King Abdulaziz University Hospital.

Authors:  Wafa M K Fageeh
Journal:  BMC Res Notes       Date:  2013-07-31

10.  Structure of the Recombinant Neisseria gonorrhoeae Adhesin Complex Protein (rNg-ACP) and Generation of Murine Antibodies with Bactericidal Activity against Gonococci.

Authors:  Ivo Tews; Myron Christodoulides; Hannia Liliana Almonacid-Mendoza; María Victoria Humbert; Aiste Dijokaite; David W Cleary; Yiwen Soo; Miao-Chiu Hung; Christian M Orr; Moritz M Machelett
Journal:  mSphere       Date:  2018-10-10       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.